Company Profile

Discover and develop the best medicine to serve patients

View More
Zenshine Pharmaceuticals Inc. was founded in 2018 by industry veterans with a track-record of successful drug discovery and development. Headquartered in Nanjing, China, Zenshine’s discovery research operation is based in Hangzhou, China and its clinical management and business development have a presence in the San Francisco bay area, USA.
Our Pipeline

Zenshine’s drug discovery and development programs involve targeting purinergic signaling in immune cells and intracellular signal transduction pathways to modulate tumor microenvironment and thus to promote immunity. Oncology - targeting cancer intrinsic and extrinsic characteristics by either directly blocking tumor growth or modulating tumor microenvironment. Anti-infection - targeting pathogen infection that threats public health.

View More
News
View All
2022-01-06
First patient received ZX-4081 treatment in the phase 1 trial
View More
2021-12-09
NMPA Approved Zenshine’s IND Application for ZX-101A as solid tumor treatment
View More
2021-09-28
NMPA Approved Zenshine’s IND Application for ZX-7101A as influenza treatment
View More